基于数据挖掘分析郝宏文治疗小儿腺样体肥大用药规律
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R725.6

基金项目:

国家中医药管理局全国名老中医药专家传承工作室建设项目(040202002003)


Administration Rule of HAO Hongwen in Treating Adenoid Hypertrophy in Children Based on Data Mining
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:基于中医传承辅助平台软件,分析总结郝宏文教授治疗小儿腺样体肥大的组方及用药规律。方法:应用中医传承辅助平台软件(V2.5),通过构建中医药治疗小儿腺样体肥大的方剂数据库,采用软件集成的数据挖掘方法,对60 首治疗小儿腺样体肥大的方剂进行用药频次、组方规律及新方分析。结果:在研究的60 首处方中,确定了处方中各种药物的使用频次、药物之间的关联规则,演化得到核心组合16 个、新处方8 个。结论:郝宏文教授治疗小儿腺样体肥大的主要治则为宣通鼻窍、补肺健脾、化痰活血。

    Abstract:

    Abstract:Objective:To analyze and summarize Prof. HAO Hongwen's prescriptions and administration rules in treating adenoidal hypertrophy in children based on Chinese Medicine Inheritance Assistant Platform software. Methods: Chinese Medicine Inheritance Assistant Platform software(V2.5) was used to construct the prescription database of Chinese medicine for adenoidal hypertrophy in children,and the software integrated data mining method was adopted to analyze the medication frequency,prescription rules and new prescriptions of 60 prescriptions for the treatment of adenoidal hypertrophy in children. Results:Among the 60 prescriptions,the frequency of use of each Chinese herb and association rules between them were determined,and 16 core combinations and 8 new prescriptions were evolved. Conclusion:The administration rules of Prof. HAO's in treating adenoidal hypertrophy in children is to promote nasal orifices,supplement the lung and fortify the spleen, dissolve phlegm and promote blood circulation.

    参考文献
    相似文献
    引证文献
引用本文

丁杰,王俊宏,王道涵,路晨,李欣怡,唐艳鹏,王晓聪,张莎莎,指导:郝宏文.基于数据挖掘分析郝宏文治疗小儿腺样体肥大用药规律[J].新中医,2021,53(10):194-198

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2021-05-24
  • 出版日期:
文章二维码